Ascendis Pharma A/s Earnings

Ascendis Pharma A/s’s revenue jumped 269.4% since last year same period to $213.63Mn in the Q3 2025. On a quarterly growth basis, Ascendis Pharma A/s has generated 35.17% jump in its revenue since last 3-months.

Ascendis Pharma A/s’s net profit jumped 38.52% since last year same period to $-60.99Mn in the Q3 2025. On a quarterly growth basis, Ascendis Pharma A/s has generated -56.97% fall in its net profits since last 3-months.

Ascendis Pharma A/s’s net profit margin jumped 83.36% since last year same period to -28.55% in the Q3 2025. On a quarterly growth basis, Ascendis Pharma A/s has generated -16.12% fall in its net profit margins since last 3-months.

Ascendis Pharma A/s’s earning per share (EPS) estimates for the current quarter stand at 0.51 - a 607.31% jump from last quarter’s estimates.

Ascendis Pharma A/s’s earning per share (EPS) estimates for the current year stand at 0.51.

Ascendis Pharma A/s’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Ascendis Pharma A/s has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.